A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease-Reference-Cited by-同舟云学术

A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease

Published:2017-10 Issue: Volume:139 Page:612-632
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Palanimuthu Duraippandi,Poon Rachal,Sahni Sumit,Anjum Rukhsana^ORCID,Hibbs David,Lin Hsuan-Yu,Bernhardt Paul V.,Kalinowski Danuta S.,Richardson Des R.

Funder

National Health and Medical Research Council (NHMRC)

NHMRC Senior Principal Research Fellowship

NHMRC RD Wright Fellowship

Australian Research Council

Sydney Medical School

Judith Jane Mason and Harold Stannett Williams Memorial Foundation

Priority driven Collaborative Cancer Research Scheme (PdCCRS)

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference106 articles.

1. The multifactorial nature of Alzheimer's disease for developing potential therapeutics;Carreiras;Curr. Top. Med. Chem.,2013

2. Alzheimer mechanisms and therapeutic strategies;Huang;Cell,2012

3. Entorhinal cortex pathology in Alzheimer's disease;Van Hoesen;Hippocampus,1991

4. Global prevalence of dementia: a Delphi consensus study;Ferri;Lancet,2005

5. The cholinergic hypothesis of Alzheimer's disease: a review of progress;Francis;J. Neurol. Neurosurg. Psychiatry,1999

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and characterization of copper(II) complex derived from newly synthesized acenaphthene quinone thiosemicarbazone ligands: Computational studies, in vitro binding with DNA/BSA and anticancer studies;Inorganica Chimica Acta;2025-01

2. Synthesis, characterization, and MAO inhibitory activities of three new drug-like N-acylhydrazone derivatives;Journal of Molecular Structure;2024-12

3. In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-22

4. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer’s Disease;Current Pharmaceutical Design;2023-12

5. Copper thiosemicarbazone modified electrode for hydrazine electrocatalytic oxidation;Results in Chemistry;2023-12